ID: ALA4172485

Max Phase: Preclinical

Molecular Formula: C16H10N4O2S

Molecular Weight: 322.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=[N+]([O-])c1ccc(N2c3ccncc3Sc3ccncc32)cc1

Standard InChI:  InChI=1S/C16H10N4O2S/c21-20(22)12-3-1-11(2-4-12)19-13-5-7-18-10-16(13)23-15-6-8-17-9-14(15)19/h1-10H

Standard InChI Key:  ZNOGJYRPBXYJFU-UHFFFAOYSA-N

Associated Targets(Human)

UO-31 46270 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.35Molecular Weight (Monoisotopic): 322.0524AlogP: 4.32#Rotatable Bonds: 2
Polar Surface Area: 72.16Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.33CX LogP: 3.01CX LogD: 2.98
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.40Np Likeness Score: -1.35

References

1. Pluta K, Jeleń M, Morak-Młodawska B, Zimecki M, Artym J, Kocięba M, Zaczyńska E..  (2017)  Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.,  138  [PMID:28734245] [10.1016/j.ejmech.2017.07.009]

Source